Atlas Venture Fund Ix, L.P. Cogent Biosciences, Inc. (COGT) insider trading activity

Atlas Venture Fund Ix, L.P. is > 10% Shareholder of Cogent Biosciences, Inc.. Currently has a direct ownership of 3.36 Million shares of COGT, which is worth approximately $26.4 Million. The most recent transaction as insider was on Apr 03, 2018, when has been sold 3,267,483 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.36M

0% 3M change

0% 12M change

Total Value Held $26.4 Million

Atlas Venture Fund IX, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 03 2018	BUY Conversion of derivative security	-	3,267,483 Added 50.0%	3,267,483 Common Stock
Apr 03 2018	BUY Open market or private purchase	$1,128,624 $12.0 p/Share	94,052 Added 2.72%	3,361,535 Common Stock

Also insider at

SURF

Surface Oncology, Inc. Healthcare

> 10% Shareholder

AVF